{
    "title": "114_hr5956",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Youth Opioid Use Treatment Help Act \nof 2016'' or the ``YOUTH Act''.\n\nSEC. 2. REAUTHORIZATION OF SUBSTANCE ABUSE TREATMENT SERVICES FOR \n              CHILDREN AND ADOLESCENTS.\n\n    (a) In General.--Section 514 of the Public Health Service Act (42 \nU.S.C. 290bb-7) is amended--\n            (1) by striking ``abuse'' and inserting ``use'' each place \n        it appears;\n            (2) by striking ``children and adolescents'' and inserting \n        ``children, adolescents, and young adults'' each place it \n        appears; and\n            (3) in subsection (f), by striking ``for fiscal years 2002 \n        and 2003'' and inserting ``for each of fiscal years 2017 \n        through 2022''.\n    (b) Technical Correction.--Section 514 of the Public Health Service \nAct (42 U.S.C. 290bb-9), as added by section 3632 of the \nMethamphetamine Anti-Proliferation Act of 2000 (Public Law 106-310; 114 \nStat. 1236), is redesignated as section 514B.\n\nSEC. 3. ACCESS TO MEDICATION-ASSISTED TREATMENT FOR ADOLESCENTS AND \n              YOUNG ADULTS DEMONSTRATION PROGRAM.\n\n    (a) In General.--The Secretary of Health and Human Services, acting \nthrough the Director of the Agency for Healthcare Research and Quality \n(in this section referred to as the ``Director''), shall award grants \nto eligible entities to establish demonstration programs to--\n            (1) expand access to medication-assisted treatment for \n        opioid use disorders among adolescents and young adults;\n            (2) identify and test solutions to overcoming barriers to \n        implementation of medication-assisted treatment for adolescents \n        and young adults; or\n            (3) create and distribute for pediatric health care \n        providers resources on medication-assisted treatment training \n        and implementation.\n    (b) Eligible Entities.--To be eligible to receive a grant under \nsubsection (a), an entity shall--\n            (1) be a State, political subdivision of a State, Indian \n        tribe, tribal organization, professional pediatric provider \n        organization, professional addiction medicine provider, \n        hospital, an institution of higher education, or other \n        appropriate public or nonprofit institution; and\n            (2) certify that it is in compliance with all applicable \n        registration and licensing requirements.\n    (c) Application.--To seek a grant under this section, an entity \nshall submit to the Director an application at such time, in such \nmanner, and containing such information as the Director may require.\n    (d) Duration.--An eligible entity may receive funds under this \nsection to carry out a demonstration program described in this section \nfor a period of not greater than 3 years. After the first year for \nwhich funding is provided to an eligible entity for a demonstration \nprogram, funding may be provided under this section for a subsequent \nyear for such program only upon review of such program by the Director \nand approval by the Director of such subsequent year of funding.\n    (e) Reports.--\n            (1) By grant recipients.--Each eligible entity awarded a \n        grant under this section for a demonstration program shall \n        submit to the Director progress reports on such demonstration \n        program at such times, in such manner, and containing such \n        information as the Director may require.\n            (2) By director.--Not later than one year after the date on \n        which all demonstration programs funded under this section have \n        been completed, the Director shall submit to the Committee on \n        Health, Education, Labor, and Pensions of the Senate, and the \n        Committee on Energy and Commerce of the House of \n        Representatives a report that--\n                    (A) describes the availability of medication-\n                assisted treatment for adolescents and young adults \n                with opioid use disorders in the United States, \n                including barriers to such treatment;\n                    (B) describes the specific demonstration programs \n                carried out pursuant to this section;\n                    (C) evaluates the effectiveness of such programs;\n                    (D) evaluates any unintended consequences of such \n                programs; and\n                    (E) provides recommendations for ensuring that \n                medication-assisted treatment is accessible to \n                adolescents and young adults with opioid use disorders.\n    (f) Definitions.--In this section:\n            (1) The phrase ``adolescents and young adults'' means \n        individuals who have attained 10 years of age and not yet \n        attained 26 years of age.\n            (2) The term ``medication-assisted treatment'' means \n        pharmacological treatments approved by the Food and Drug \n        Administration, in combination with counseling and behavioral \n        therapies.\n            (3) The term ``opioid use disorder'' means a substance use \n        disorder that is a problematic pattern of opioid use leading to \n        clinically significant impairment or distress occurring within \n        a 12-month period.\n            (4) The term ``pediatric health care provider'' means a \n        provider of health care to individuals who have attained 10 \n        years of age and not yet attained 26 years of age.\n            (5) The term ``professional pediatric provider \n        organization'' means a national organization whose members \n        consist primarily of pediatric health care providers.\n    (g) Authorization of Appropriations.--There is authorized to be \nappropriated $5,000,000 to carry out this section.\n\nSEC. 4. GAO STUDY AND REPORT ON PROGRAMS AND RESEARCH RELATIVE TO \n              SUBSTANCE USE AND SUBSTANCE USE DISORDERS AMONG \n              ADOLESCENTS AND YOUNG ADULTS.\n\n    (a) Study.--The Comptroller General of the United States shall \nconduct a study on how Federal agencies are addressing prevention of, \ntreatment for, and recovery from substance use by and substance use \ndisorders among adolescents and young adults. Such study shall include \nan analysis of each of the following:\n            (1) The research that has been, and is being, conducted or \n        supported by the Federal Government on prevention of, treatment \n        for, and recovery from substance use by and substance use \n        disorders among adolescents and young adults, including an \n        assessment of--\n                    (A) such research relative to any unique \n                circumstances (including social and biological \n                circumstances) of adolescents and young adults that may \n                make adolescent-specific and young adult-specific \n                treatment protocols necessary, including any effects \n                that substance use and substance use disorders may have \n                on brain development and the implications for treatment \n                and recovery; and\n                    (B) areas of such research in which greater \n                investment or focus is necessary relative to other \n                areas of such research.\n            (2) The Federal non-research programs and activities that \n        address prevention of, treatment for, and recovery from \n        substance use by and substance use disorders among adolescents \n        and young adults, including an assessment of the effectiveness \n        of such programs and activities in preventing substance use by \n        and substance use disorders among adolescents and young adults, \n        treating such adolescents and young adults in a way that \n        accounts for any unique circumstances faced by adolescents and \n        young adults, and supports long-term recovery among adolescents \n        and young adults.\n            (3) Gaps that have been identified by Federal officials and \n        experts in Federal efforts relating to prevention of, treatment \n        for, and recovery from substance use by and substance use \n        disorders among adolescents and young adults, including gaps in \n        research, data collection, and measures to evaluate the \n        effectiveness of Federal efforts, and the reasons for such \n        gaps.\n    (b) Report.--Not later than 2 years after the date of enactment of \nthis Act, the Comptroller General shall submit to the appropriate \ncommittees of the Congress a report containing the results of the study \nconducted under subsection (a), including--\n            (1) a summary of the findings of the study; and\n            (2) recommendations based on the results of the study, \n        including recommendations for such areas of research and \n        legislative and administrative action as the Comptroller \n        General determines appropriate."
}